1 Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324–43.
2 SpirXpert Become an expert in spirometry. (Accessed November 24, 2017, at
http://spirxpert.ers-education.org/en/spirometry/welcome-to-spirxpert/.)
3 Bridevaux PO, Dupuis-Lozeron E, Schindler C, et al. Spirometer Replacement and Serial Lung Function Measurements in Population Studies: Results From the SAPALDIA Study. Am J Epidemiol. 2015;181:752–61.
4 Quanjer PH, Stanojevic S. Do the Global Lung Function Initiative 2012 equations fit my population? Eur Respir J. 2016;48:1782–5.
5 Culver BH, Graham BL, Coates AL, et al. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med. 2017;196:1463–72.
6 Brunelli A, Charloux A, Bolliger CT, et al. The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer. Eur J Cardiothorac Surg. 2009;36:181–4.
7 Hughes JM, Pride NB. Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components. Am J Respir Crit Care Med. 2012;186:132–9.
8 Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. [Lung volumes and forced ventilatory flows. Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society]. Rev Mal Respir. 1994;11 Suppl 3:5–40.
9 Global strategy for asthma management and prevention (GINA). 2018. http://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/
10 Vremaroiu P, Gex G, Bridevaux PO. [Bronchodilatation during spirometry : indications, realization and interpretation]. Rev Med Suisse. 2016;12:1483–7.
11 Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2018 2017. (Accessed January 12, 2018, at
http://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf.)
12 Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–68.
13 Quanjer PH, Stanojevic S, Thompson BR. Spirometric thresholds and biased interpretation of test results. Thorax. 2014;69:1146.
14 Quanjer PH, Weiner DJ, Pretto JJ, Brazzale DJ, Boros PW. Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making. Eur Respir J. 2014;43:1051–8.
15 McGeachie MJ, Yates KP, Zhou X, et al. Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med. 2016;374:1842–52.
16 Bateman ED, Reddel HK, van Zyl-Smit RN, Agusti A. The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? Lancet Respir Med. 2015;3:719–28.
17 Brusasco V, Crapo R, Viegi G. Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J. 2005;26:1–2.
18 Dosieraerosol mit spacer demonstration video. (Accessed june 14, 2016, at
http://www.atemwegsliga.de/dosieraerosol-spacer.html.)
19 Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:–40.
20 Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59 Suppl 1:1–232.